Medpace Holdings, Inc. Common Stock MEDP
HEALTHCARE · DIAGNOSTICS & RESEARCHi
Market dataready · fetched 2026-11-12T02:49:44.479Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T21:00:01.138296543Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-12T02:49:44.091669+00:00
Medpace Holdings, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 705.27 | 42.1% | 6.8% | 629.88 | 43.3% | 6.0% |
| 25Δ | 695.71 | 39.8% | 5.6% | 639.50 | 39.2% | 4.7% |
| 30Δ | 687.85 | 38.2% | 4.6% | 645.56 | 38.7% | 4.1% |
| 35Δ | 683.00 | 40.0% | 4.2% | 651.25 | 38.6% | 3.5% |
| 40Δ | 677.82 | 40.9% | 3.7% | 656.37 | 39.2% | 3.1% |
| 45Δ | 672.13 | 40.1% | 3.2% | 661.47 | 39.3% | 2.7% |
| 50Δ | 666.71 | 40.1% | 2.7% | 666.49 | 38.1% | 2.2% |
| 55Δ | 661.44 | 40.4% | 2.3% | 671.49 | 37.2% | 1.8% |
| 60Δ | 656.15 | 40.2% | 2.0% | 676.44 | 36.9% | 1.5% |
| 65Δ | 650.84 | 39.8% | 1.6% | 681.52 | 36.6% | 1.2% |
| 70Δ | 644.88 | 40.1% | 1.3% | 686.94 | 36.4% | 1.0% |
| 75Δ | 638.53 | 40.7% | 1.1% | 692.17 | 35.6% | 0.7% |
| 80Δ | 631.01 | 41.7% | 0.8% | 697.16 | 34.0% | 0.5% |
20Δ
- Pseudo strike
- 705.27
- IV
- 42.1%
- B/E move
- 6.8%
- Pseudo strike
- 629.88
- IV
- 43.3%
- B/E move
- 6.0%
25Δ
- Pseudo strike
- 695.71
- IV
- 39.8%
- B/E move
- 5.6%
- Pseudo strike
- 639.50
- IV
- 39.2%
- B/E move
- 4.7%
30Δ
- Pseudo strike
- 687.85
- IV
- 38.2%
- B/E move
- 4.6%
- Pseudo strike
- 645.56
- IV
- 38.7%
- B/E move
- 4.1%
35Δ
- Pseudo strike
- 683.00
- IV
- 40.0%
- B/E move
- 4.2%
- Pseudo strike
- 651.25
- IV
- 38.6%
- B/E move
- 3.5%
40Δ
- Pseudo strike
- 677.82
- IV
- 40.9%
- B/E move
- 3.7%
- Pseudo strike
- 656.37
- IV
- 39.2%
- B/E move
- 3.1%
45Δ
- Pseudo strike
- 672.13
- IV
- 40.1%
- B/E move
- 3.2%
- Pseudo strike
- 661.47
- IV
- 39.3%
- B/E move
- 2.7%
50Δ
- Pseudo strike
- 666.71
- IV
- 40.1%
- B/E move
- 2.7%
- Pseudo strike
- 666.49
- IV
- 38.1%
- B/E move
- 2.2%
55Δ
- Pseudo strike
- 661.44
- IV
- 40.4%
- B/E move
- 2.3%
- Pseudo strike
- 671.49
- IV
- 37.2%
- B/E move
- 1.8%
60Δ
- Pseudo strike
- 656.15
- IV
- 40.2%
- B/E move
- 2.0%
- Pseudo strike
- 676.44
- IV
- 36.9%
- B/E move
- 1.5%
65Δ
- Pseudo strike
- 650.84
- IV
- 39.8%
- B/E move
- 1.6%
- Pseudo strike
- 681.52
- IV
- 36.6%
- B/E move
- 1.2%
70Δ
- Pseudo strike
- 644.88
- IV
- 40.1%
- B/E move
- 1.3%
- Pseudo strike
- 686.94
- IV
- 36.4%
- B/E move
- 1.0%
75Δ
- Pseudo strike
- 638.53
- IV
- 40.7%
- B/E move
- 1.1%
- Pseudo strike
- 692.17
- IV
- 35.6%
- B/E move
- 0.7%
80Δ
- Pseudo strike
- 631.01
- IV
- 41.7%
- B/E move
- 0.8%
- Pseudo strike
- 697.16
- IV
- 34.0%
- B/E move
- 0.5%
Options history
Table
| Date | IV (%) |
|---|---|
| 50.85% | |
| 51.84% | |
| 51.53% | |
| 34.88% | |
| 34.62% | |
| 34.57% | |
| 34.26% | |
| 33.70% | |
| 34.49% | |
| 36.18% |
Diagnostics & Research
MTD
Mettler Toledo (NYSE: MTD) is a multinational manufacturer of scales and analytical instruments. It is the largest provider of weighing instruments for use in laboratory,…
More →MYGN
Myriad Genetics, Inc., a molecular diagnostics company, develops and markets predictive, personalized, and prognostic medicine tests in the United States and internationally. The…
More →NEO
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. The company is headquartered in Fort Myers, Florida.
More →NTRA
Natera, Inc., a diagnostic company, develops and markets molecular testing services globally. The company is headquartered in San Carlos, California.
More →OPK
OPKO Health, Inc., a healthcare company, is engaged in the pharmaceutical and diagnostic businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and…
More →PSNL
Personalis, Inc. is a global cancer genomics company. The company is headquartered in Menlo Park, California.
More →